Author

B. Grygielska

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

J. Rayes· 2 shared A. Brill· 1 shared A. Croft· 1 shared A. O. Khan· 1 shared A. Rodriguez-Romera· 1 shared A. Roy· 1 shared A. Stone· 1 shared B. Psaila· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

J. Rayes

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Spleen tyrosine kinase inhibition mitigates hemin-induced thromboinflammation in the lung and kidney of sickle cell mice

J. El-Awaisi, G. Perrella, N. Mayor, V. Tinkova, S. J. Cleary, B. Grygielska, S. P. Watson, J. D. Dimitrov, A. Brill, P. L. Nicolson, D. Kavanagh, N. Kalia, J. Rayes

This study shows that Syk inhibition reduces hemin-induced thromboinflammation and improves perfusion in the lungs and kidneys of sickle cell mice.

bioRxiv · May 4, 2024 · PreprintPathology

Human bone marrow organoids for disease modelling, discovery and validation of therapeutic targets in hematological malignancies

A. O. Khan, M. Colombo, J. S. Reyat, G. Wang, A. Rodriguez-Romera, W. X. Wen, L. Murphy, B. Grygielska, C. Mahony, A. Stone, A. Croft, D. C. Bassett, G. Pooligasundarampillai, A. Roy, S. Gooding, , B. Psaila

This paper develops human bone marrow organoids to model hematological malignancies and validate therapeutic targets.

bioRxiv · Mar 14, 2022Cancer Biology